ARTICLE | Regulation
U.K. pairs green light for AZ-Oxford vaccine with aggressive distribution scheme to prioritize saving more lives
Emergency authorization prioritizes widespread vaccination via flexible dosing schedule
December 30, 2020 3:50 PM UTC
The U.K.’s emergency authorization of the COVID-19 vaccine from AstraZeneca and the University of Oxford prioritizes widespread vaccination with a flexible dosing schedule that’s supported by recent data showing up to 70% efficacy for a single dose.
The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) announced Wednesday the emergency authorization of COVID-19 Vaccine AstraZeneca (formerly AZD1222 ). It marks the first authorization of the vaccine from AstraZeneca plc (LSE:AZN; NASDAQ:AZN) and the University of Oxford in the world...